Apoptosis modulators in the therapy of neurodegenerative diseases.

@article{Deigner2000ApoptosisMI,
  title={Apoptosis modulators in the therapy of neurodegenerative diseases.},
  author={Hans Peter Deigner and Uwe Haberkorn and Ralf Kinscherf},
  journal={Expert opinion on investigational drugs},
  year={2000},
  volume={9 4},
  pages={747-64}
}
Apoptosis is a prerequisite to model the developing nervous system. However, an increased rate of cell death in the adult nervous system underlies neurodegenerative disease and is a hallmark of multiple sclerosis (MS) Alzheimer's- (AD), Parkinson- (PD), or Huntington's disease (HD). Cell surface receptors (e.g., CD95/APO-1/Fas; TNF receptor) and their ligands (CD95-L; TNF) as well as evolutionarily conserved mechanisms involving proteases, mitochondrial factors (e.g. , Bcl-2-related proteins… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

Similar Papers

Loading similar papers…